Expert Reviews in Molecular Medicine

 



Review Article

Lyme borreliosis (Lyme disease): molecular and cellular pathobiology and prospects for prevention, diagnosis and treatment


Paul G. Auwaerter a1, John Aucott a2 and J. Stephen Dumler a3c1
a1 Divisions of General Internal Medicine and Infectious Diseases, The Johns Hopkins University School of Medicine, 10753 Falls Road, Suite 325, Lutherville, MD 21093, USA.
a2 Divisions of General Internal Medicine and Infectious Diseases, The Johns Hopkins University School of Medicine, Park Medical Associates, Suite 200, Greenspring Station, 10755 Falls Road, Baltimore, MD 21093, USA.
a3 Division of Medical Microbiology, Department of Pathology, The Markey Graduate Program in Cellular and Molecular Medicine, The Johns Hopkins University School of Medicine, Department of Molecular Microbiology and Immunology, The Johns Hopkins University Bloomberg School of Public Health, Ross Research Building, Room 624, 720 Rutland Avenue, Baltimore, MD 21205, USA.

Abstract

Lyme borreliosis is a systemic infection caused by the spirochaete Borrelia burgdorferi, which is transmitted by tick bites and maintained in a delicately balanced ecological cycle. Recent increases in the population densities of tick hosts, the abundance of ticks and the proximity of man to natural tick habitats have led to an escalating worldwide incidence of Lyme borreliosis, and nonspecific clinical manifestations have yielded significant misunderstanding of the disease. After entry, B. burgdorferi activates local inflammation, yet evades host defences and facilitates dissemination by potentially masquerading with host components such as plasmin and complement. The extent of tissue injury is determined by the aggressiveness of host inflammation and immunological reactions, as well as by genetic attributes of the spirochaete. The clinical presentation can be highly varied, including early manifestations that are limited to erythema migrans and ranging to disseminated infection with arthritis, carditis, cranial nerve palsy, peripheral neuropathy, meningitis, or other manifestations. Diagnostic tests have improved, but are unhelpful during certain stages of infection. Therapy varies depending on the degree of involvement, and recovery is usually rapid and complete. Post-treatment clinical manifestations in the absence of evidence for active infection are still poorly understood. The understanding of how B. burgdorferi survives in the environment and interacts with human and mammalian hosts has improved. However, further advances in prevention and therapy depend on continued investigation of the ecological risks and improved understanding of the pathobiology of this obligate bacterial parasite.


Key Words: Lyme disease; Borrelia burgdorferi; erythema migrans; arthritis; meningitis; genome sequence; plasmin; complement; vaccine; antibiotic therapy; ticks.

Correspondence:
c1 Division of Medical Microbiology, Department of Pathology, The Markey Graduate Program in Cellular and Molecular Medicine, The Johns Hopkins University School of Medicine, Department of Molecular Microbiology and Immunology, The Johns Hopkins University Bloomberg School of Public Health, Ross Research Building, Room 624, 720 Rutland Avenue, Baltimore, MD 21205, USA. Tel: +1 410 955 8654; Fax: +1 443 287 3665; E-mail: sdumler@jhmi.edu